Capstone Technologies Group Inc. announced the appointment of Frank Knuettel to its board of directors. Knuettel is a strong operational and strategic executive officer with 30 years of management experience in venture-backed and small-cap public companies. He has spent most of his career as a Chief Financial or Chief Strategic Officer in early-stage, dynamic technology and life sciences companies with a strong track record in growing organizations. Mr. Knuettel currently manages Camden Capital LLC where he provides fractional and interim CXO and board services, including as CFO of two Nasdaq listed SPACs and Interim CEO of Chromocell Therapeutics Corp.

Among his achievements, he co-founded a fabless semiconductor company as the CFO and assumed responsibility for management of the supply chain and operations, prior to selling the company to an established semiconductor company and was CFO of a fintech platform through its considerable growth prior to selling to a large payment processor. Mr. Knuettel also holds numerous board positions, at both public and private companies, including 180 Life Sciences, ECOM Medical, and Relativity Acquisition Corp. Mr. Knuettel received his BA with honors in Economics from Tufts University and holds an MBA in Finance and Entrepreneurial Management from The Wharton School at the University of Pennsylvania.